The World Health Organization (WHO) has said that remdesivir has had little or no effect on coronavirus patients' length of hospital stay or chances of survival.

Remdesivir did not cut hospital stay or mortality in virus patients: WHO

The California-based drug makeing comoany Gilead Sciences has, after numerous months, got a green signal in Hong Kong for the usage of Remdesivir drug against coronavirus.

COVID 19: Gilead's Remdesivir gets a conditional green signal in Hong Kong

With a rapid increase in the number of coronavirus cases in India, the country is gearing up to start domestic production of the anti-viral Remdesivir drug. The drug will be allowed only for "restricted emergency use" on COVID-19 patients.

COVID 19: India to start domestic production of Remdesivir

The Wuhan virus has infected more than 72,00,000 people across the world. A new study in the Medical Journal Nature says that anti-viral drug Remdesivir can help prevent Lung damage in infected patients. WION's Palki Sharma gets you a report.

Gravitas: Can Remdesivir slow Covid-19 progression?

remdesivir-drug

Remdesivir Drug, News on Remdesivir Drug, stories on Remdesivir Drug, articles on Remdesivir Drug, Remdesivir Drug stories at Wion, Remdesivir Drug news, Remdesivir Drug latest news

remdesivir drug

Remdesivir did not cut hospital stay or mortality in virus patients: WHO

COVID 19: Gilead's Remdesivir gets a conditional green signal in Hong Kong

COVID 19: India to start domestic production of Remdesivir

Gravitas: Can Remdesivir slow Covid-19 progression?